
Aymen Ahmed
@aymenahmed_
MS5 @Dow_uni | Outcomes Researcher | Mentor @R_C_O_P | Guest Editor @PLOSONE | Peer Reviewer @EJPC | Aspiring Cardiologist #Medtwitter
ID: 1343145888772980736
27-12-2020 10:45:22
75 Tweet
369 Followers
449 Following

Extremely humbled to be appointed as a guest editor at PLOS One. Immensely grateful to all mentors at Research Council of Pakistan for their constant guidance and support! Tariq Jamal Siddiqi Muhammad Shariq Usman Shahzeb Khan Kaneez Fatima




So honoured to be a part of this list !! European Society of Cardiology Journals doi.org/10.1093/eurjpc…


Out in JAHA, our meta-analysis evaluates the prevalence & types of #HTN‐mediated organ damage & the prognosis of pts presenting to the #ED with hypertensive emergencies. Immensely grateful to Drs.Tariq Jamal Siddiqi & Muhammad Shariq Usman for the opportunity! doi.org/10.1161/jaha.1…


📌EHJ Editor-in-Chief Global Spotlight: Creation of next generation of diverse CV Physician-Scientists from Developing Countries: Insights from Research Council of Pakistan 📌A 📝 very close to my heart. Structured long term research mentorship is vital at every level- esp for med students (1/3)


Guess what arrived in my mailbox today?🙈 European Society of Cardiology Journals Grateful to all my mentors who have supported and guided me throughout!


Feels surreal to have our abstract discussing bariatric surgery in adolescents accepted at #ASC2024. Assoc4AcademicSurgery Aga Khan University Kinza Jawed Aymen Ahmed Mehak Barolia Russell Seth Martins


MedDiet adherence shows promise in reducing EAT, which can help prevent AF🫀. Read our editorial 📝 under the mentorship of Shahzeb Khan on PREDIMAR sub-study in this issue of European Society of Cardiology Journals Editorial: doi.org/10.1093/eurjpc… Article: doi.org/10.1093/eurjpc… Aymen Ahmed


Takeaways from #ACC2025. Late breaking trials - take home points American College of Cardiology 1. WARRIOR Trial : Intensive medical therapy did not significantly impact the rate of serious cardiovascular events at five years in women with suspected ischemia with nonobstructive coronary arteries